Metformin vs Rapamycin
Independent, side-by-side comparison of Metformin and Rapamycin: mechanism, half-life, dose range, safety profile, and live vendor pricing. Updated continuously as new research and listings land.
Live price snapshot
Metformin
Rapamycin
Metformin
Metformin is a biguanide-class oral antihyperglycemic medication that has been in continuous clinical use since 1957 (in France under the brand name Glucophage) and is now the most-prescribed diabetes medication…
Full Metformin profileRapamycin
Rapamycin is a macrocyclic lactone antibiotic discovered in 1972 in soil samples from Rapa Nui (Easter Island) by a bacteriology survey team investigating indigenous Streptomyces species. Named after its place of…
Full Rapamycin profileSide-by-side comparison
| Attribute | Metformin | Rapamycin |
|---|---|---|
| Category | Metabolic | Longevity |
| Research Stage | Preclinical | Preclinical |
| Mechanism of Action | Metformin's molecular mechanism of action has been progressively elucidated over decades and now involves multiple overlapping pathways, though which pathway dominates in any given tissue context remains contested. The classical view centers on mitochondrial… | Rapamycin's mechanism of action centers on its inhibition of the mechanistic target of rapamycin (mTOR), a central serine-threonine kinase that integrates nutrient, growth factor, and stress signals to regulate cellular growth, protein synthesis, autophagy,… |
| Half-Life | — | — |
| Typical Dose Range | — | — |
| Dosing Frequency | — | — |
| Administration | — | — |
| Side Effects | Metformin has a well-characterized side effect profile dominated by GI tolerability issues that are usually manageable and a rare but serious lactic acidosis risk that warrants attention in specific clinical contexts. Common GI side effects affect 20-30% of… | Rapamycin has a well-characterized side-effect profile developed over decades of transplant use. The profile at longevity doses (weekly 5-8 mg) is substantially milder than at transplant doses (continuous daily dosing targeting 5-15 ng/mL trough levels), but… |
| Molecular Weight | — | — |
| Common Vial Sizes | — | — |
Frequently asked
What's the difference between Metformin and Rapamycin?
Metformin is a metabolic that metformin's molecular mechanism of action has been progressively elucidated over decades and now involves multiple overlapping pathways, though which pathway dominates in any given…. Rapamycin is a longevity that rapamycin's mechanism of action centers on its inhibition of the mechanistic target of rapamycin (mtor), a central serine-threonine kinase that integrates nutrient, growth factor,…. The two differ in mechanism, half-life (not reported vs not reported), and typical dose range.
Which has the longer half-life, Metformin or Rapamycin?
Metformin has a half-life of not reported. Rapamycin has a half-life of not reported. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Can you stack Metformin and Rapamycin?
Stacking depends on mechanism overlap, safety profile, and goals. Metformin and Rapamycin should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Live listings from the vendors we track, refreshed continuously.
Related comparisons
Research use only. BodyHackGuide is an independent research reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. We earn an affiliate commission on some outbound clicks — this never affects the data or pricing shown. See editorial standards and affiliate disclosure.